Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

This effort, undertaken by Bristol Myers Squibb and agency partner Real Chemistry, is part of the Champions in Care campaign.

Bristol Myers Squibb is axing another big bet from the Caforio era, terminating a deal for Agenus’ TIGIT bispecific antibody three years after paying $200 million to buy into the program. Agenus ...

He brings a wealth of insurer and client relationships alongside his own deep industry knowledge,' says director ...

One of the household goods carriers owned by a billion-dollar, St. Louis-area transportation firm has added a new owner-agent ...